Search Results - David O. Irving

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Revaccination with Measles, Tetanus, Poliovirus, Haemophilus influenzae Type B, Meningococcus C, and Pneumococcus Vaccines in Children after Hematopoietic Stem Cell Transplantation

    Revaccination with Measles, Tetanus, Poliovirus, Haemophilus influenzae Type B, Meningococcus C, and Pneumococcus Vaccines in Children after Hematopoietic Stem Cell Transplantation by Shitalben Patel, Miguel Ortín, B J Cohen, Ray Borrow, David O. Irving, Joanne E. Sheldon, Paul T. Heath

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October – December 2009

    Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October – December 2009 by Jodie McVernon, Karen L. Laurie, T. Nolan, Rhonda Owen, David O. Irving, Hugh Capper, Catherine A. Hyland, Helen M. Faddy, Louise Carolan, Ian Barr, Anne Kelso

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults

    Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults by D. James Cooper, Zoe McQuilten, Alistair Nichol, Bridget Ady, Cécile Aubron, Michael Bailey, Rinaldo Bellomo, Dashiell Gantner, David O. Irving, Kirsi‐Maija Kaukonen, Colin McArthur, Lynne Murray, Ville Pettilä, Craig French

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A Recombinant Blood‐Stage Malaria Vaccine Reduces<i>Plasmodium falciparum</i>Density and Exerts Selective Pressure on Parasite Populations in a Phase 1–2b Trial in Papua New Guinea

    A Recombinant Blood‐Stage Malaria Vaccine Reduces<i>Plasmodium falciparum</i>Density and Exerts Selective Pressure on Parasite Populations in a Phase 1–2b Trial in Papua New Guinea... by Blaise Genton, Inoni Betuela, Ingrid Felger, Fadwa Al‐Yaman, Robin F. Anders, Allan Saul, Lawrence Rare, Moses Baisor, Kerry Lorry, Graham V. Brown, David Pye, David O. Irving, Thomas Smith, Hans‐Peter Beck, Michael P. Alpers

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020

    Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020 by Heather F. Gidding, Dorothy A. Machalek, Alexandra Hendry, Helen Quinn, Kaitlyn Vette, Frank Beard, Hannah Shilling, Rena Hirani, Iain B. Gosbell, David O. Irving, Linda Hueston, Marnie Downes, John B. Carlin, Matthew O’Sullivan, Dominic E. Dwyer, John Kaldor, Kristine Macartney

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays

    SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays by Gregory J. Walker, Zin Naing, Alberto Ospina Stella, Malinna Yeang, Joanna Caguicla, Vidiya Ramachandran, Sonia R. Isaacs, David Agapiou, Rowena A. Bull, Sacha Stelzer‐Braid, James Daly, Iain B. Gosbell, Veronica C. Hoad, David O. Irving, Joanne Pink, Stuart Turville, Anthony D. Kelleher, William D. Rawlinson

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with<i>piggyBac</i>-modified CD19 CAR T cells

    Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with<i>piggyBac</i>-modified CD19 CAR T cells by David Bishop, Leighton Clancy, Renee Simms, Jane Burgess, Geetha Mathew, Leili Moezzi, Janine Street, Gaurav Sutrave, Elissa Atkins, Helen M. McGuire, Brian Gloss, Koon Lee, Wei Jiang, Karen Maddock, Georgia McCaughan, Selmir Avdic, Vicki Antonenas, Tracey O’Brien, Peter J. Shaw, David O. Irving, David Gottlieb, Emily Blyth, Kenneth Micklethwaite

    Published 2021
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  8. 8
    Differences in the product characteristics and clinical use of granulocytes for transfusion: The <scp>BEST</scp> Collaborative study

    Differences in the product characteristics and clinical use of granulocytes for transfusion: The <scp>BEST</scp> Collaborative study by Lorna Cain, Christian Lafrance, Suzy Morton, Catherine Latour, M Girard, Pierre Tiberghien, Virginie De La Taille, Suvro Sankha Datta, Mrigender Virk, Jennifer Andrews, Vered Yahalom, A. Pugliese, Romina Alba, Richard Charlewood, Susy Kirwan, Ana Paula Hitomi Yokoyama, José Mauro Kutner, Eva Alonso Nogués, Nuria Martinez i Llonch, James Daly, David O. Irving, Torsten J. Schulze, Elise J. Huisman, Kaatje Le Poole, Hans Vrielink, Nabiha H. Saifee, Monica B. Pagano, Simon Stanworth

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

    SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants by Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, D.R. Darley, Deepti Pilli, Daniele Vitale, Vera Merheb, Fiona X. Z. Lee, Philip Cunningham, Gregory J. Walker, Christina Fichter, David A. Brown, William D. Rawlinson, Sonia R. Isaacs, Vennila Mathivanan, Markus Hoffmann, Stefan Pöhlman, Ohan Mazigi, Daniel Christ, Dominic E. Dwyer, Rebecca J. Rockett, Vitali Sintchenko, Veronica C. Hoad, David O. Irving, Gregory J. Dore, Iain B. Gosbell, Anthony D. Kelleher, Gail Matthews, Fabienne Brilot, Stuart Turville

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: